TY - JOUR
T1 - Remote monitoring
T2 - Doomed to let down or an attractive promise?
AU - Luca, Fabiana
AU - Cipolletta, Laura
AU - Di Fusco, Stefania Angela
AU - Iorio, Annamaria
AU - Pozzi, Andrea
AU - Rao, Carmelo Massimiliano
AU - Ingianni, Nadia
AU - Benvenuto, Manuela
AU - Madeo, Andrea
AU - Fiscella, Damiana
AU - Benedetto, Daniela
AU - Francese, Giuseppina Maura
AU - Gelsomino, Sandro
AU - Zecchin, Massimo
AU - Gabrielli, Domenico
AU - Gulizia, Michele Massimo
N1 - Publisher Copyright:
© 2019
PY - 2019/9
Y1 - 2019/9
N2 - Device interrogation and management are time consuming, representing a relevant burden for pacing centers. In several situations, patients management requires additional follow up visits.Remote Monitoring (RM) allows an optimal recall management and a rapid diagnosis of device or lead failure, without the need of additional in office visits. Further it allows a significant delay reduction between the adverse event and the reaction to the alarm, shortening the time needed to make a clinical decision. A role in risk-predicting patient-related outcomes has also been shown. RM permits detection of the arrhythmia from 1 to 5 months in advance compared to in-office visits. Importantly, by using specific algorithms with multiparametric analysis, RM has been studied as a potential instrument to identify early patients on risk of worsening HF using specific algorithms. Although the use of RM in HF setting remains controversial, it has been proposed to improve HF clinical outcomes and survival in clinical trials. In this sense. RM success could require a standardization of process within a management model, that may involve different health care professionals. In this review, we examine recent advances of RM providing an update of this tool through different clinical scenarios. Published by Elsevier B.V.
AB - Device interrogation and management are time consuming, representing a relevant burden for pacing centers. In several situations, patients management requires additional follow up visits.Remote Monitoring (RM) allows an optimal recall management and a rapid diagnosis of device or lead failure, without the need of additional in office visits. Further it allows a significant delay reduction between the adverse event and the reaction to the alarm, shortening the time needed to make a clinical decision. A role in risk-predicting patient-related outcomes has also been shown. RM permits detection of the arrhythmia from 1 to 5 months in advance compared to in-office visits. Importantly, by using specific algorithms with multiparametric analysis, RM has been studied as a potential instrument to identify early patients on risk of worsening HF using specific algorithms. Although the use of RM in HF setting remains controversial, it has been proposed to improve HF clinical outcomes and survival in clinical trials. In this sense. RM success could require a standardization of process within a management model, that may involve different health care professionals. In this review, we examine recent advances of RM providing an update of this tool through different clinical scenarios. Published by Elsevier B.V.
KW - Implantable devices
KW - Heart failure
KW - Atrial fibrillation
KW - Remote telemonitoring
KW - IMPLANTABLE ELECTRONIC DEVICES
KW - SUBCLINICAL ATRIAL-FIBRILLATION
KW - HEART-FAILURE HOSPITALIZATIONS
KW - FOLLOW-UP
KW - EXPERT CONSENSUS
KW - RANDOMIZED-TRIAL
KW - ESC GUIDELINES
KW - DEFIBRILLATOR
KW - MANAGEMENT
KW - RECIPIENTS
U2 - 10.1016/j.ijcha.2019.100380
DO - 10.1016/j.ijcha.2019.100380
M3 - (Systematic) Review article
SN - 2352-9067
VL - 24
JO - IJC Heart and Vasculature
JF - IJC Heart and Vasculature
M1 - 100380
ER -